{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:44:13Z","timestamp":1777866253242,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010442","name":"Universidad Nacional de C\u00f3rdoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT IP COVID 19-0464"],"award-info":[{"award-number":["PICT IP COVID 19-0464"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019946","name":"Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Estadual de Campinas","doi-asserted-by":"publisher","award":["4371"],"award-info":[{"award-number":["4371"]}],"id":[{"id":"10.13039\/501100019946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.10.021","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:22:34Z","timestamp":1666236154000},"page":"6706-6710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7832-2833","authenticated-orcid":false,"given":"Sebasti\u00e1n","family":"Blanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Spinsanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Javier Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Elisa Rivarola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Beranek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmer","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaldo","family":"Mangeaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Salom\u00e9 Konigheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Ver\u00f3nica Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2022.10.021_b0005","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune response against SARS CoV 2 variantes after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.10.021_b0010","article-title":"Covid-19: Sweden, Norway, and Finland suspend use of Moderna vaccine in young people \u201cas a precaution\u201d","volume":"375","author":"Parterlini","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.vaccine.2022.10.021_b0015","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/s41591-021-01463-x","article-title":"A \u201cmix and match\u201d approach to SARS CoV 2 vaccination","volume":"27","author":"Deming","year":"2021","journal-title":"Nat Med"},{"issue":"6584","key":"10.1016\/j.vaccine.2022.10.021_b0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.abn2688","article-title":"Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1\/mRNA-1273 vaccination","volume":"375","author":"Kaku","year":"2022","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.vaccine.2022.10.021_b0025","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 n CoV-19 Covid-19 vaccine against the B.1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"issue":"148","key":"10.1016\/j.vaccine.2022.10.021_b0030","article-title":"Adopting and heterologous prime-boost strategy in COVID-19 vaccination, the need for locally generated evicence in Africa","volume":"41","author":"Aigbiremo","year":"2022","journal-title":"PAMJ"},{"issue":"5","key":"10.1016\/j.vaccine.2022.10.021_b0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.vaccine.2021.12.027","article-title":"Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in Argentinean cohort","volume":"40","author":"Blanco","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.10.021_b0040","article-title":"Immunogenicity induced by the use of alternaive vaccine platforms to deal wit vaccine shortages in a low- to middle-income country: results of two randomized clinical trials","volume":"9","author":"Macchia","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.vaccine.2022.10.021_b0045","doi-asserted-by":"crossref","unstructured":"Blanco S, Aguilar JJ, Konigheim BS, et al. The extent of infectious SARS-CoV-2 shedding in an Argentinean cohort. J Public Health 2021:fdab145. doi: 10.1093\/pubmed\/fdab145.","DOI":"10.1093\/pubmed\/fdab145"},{"key":"10.1016\/j.vaccine.2022.10.021_b0050","doi-asserted-by":"crossref","unstructured":"Mangeaud A, El\u00edas Panigo D. R-Medic. Un programa de an\u00e1lisis estad\u00edsticos sencillo e intuitivo. Methodo 2018;3(1):18\u201322. URL http:\/\/www.r-medic.com.","DOI":"10.22529\/me.2018.3(1)05"},{"key":"10.1016\/j.vaccine.2022.10.021_b0055","unstructured":"Di Rienzo JA, Casanoves F, Balzarini MG, et al. InfoStat versi\u00f3n 2020. Grupo InfoStat, FCA, Universidad Nacional de C\u00f3rdoba, Argentina. URL: http:\/\/www.infostat.com [Last accessed September 2022]."},{"key":"10.1016\/j.vaccine.2022.10.021_b0060","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"issue":"7890","key":"10.1016\/j.vaccine.2022.10.021_b0065","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-04120-y","article-title":"Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination","volume":"600","author":"Pozzetto","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.021_b0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/infdis\/jiab556","article-title":"Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine","volume":"225","author":"Saciuk","year":"2022","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2022.10.021_b0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association between 3 doses of mRNA COVID-19 Vaccine and symptomatic Infection caused by the SARS-CoV-2 Omicron and Delta Variants","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.10.021_b0080","unstructured":"Singh Bajaj S, Maki L, Stanford FC. Vaccine apartheid: global cooperation and equity. Lancet 2022;S0140-6736(22)00328-2 doi: 10.1016\/S0140-6736(22)00328.2."},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.021_b0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41562-022-01289-8","article-title":"Equitable access to ovid-19 vaccines makes life-saving difference to all countries","volume":"6","author":"Ye","year":"2022","journal-title":"Nat Hum Behav"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.021_b0090","first-page":"286","article-title":"Optimizing COVID-19 vaccination programs during vaccine shortages","volume":"7","author":"Liu","year":"2022","journal-title":"Infect Dis Model"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:18:20Z","timestamp":1777537100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2201283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":18,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X2201283X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}